{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T21:13:32Z","timestamp":1724966012625},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.pnpbp.2005.04.024","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T13:41:54Z","timestamp":1119620514000},"page":"763-766","source":"Crossref","is-referenced-by-count":10,"title":["Long-term treatment of adjunctive quetiapine for bipolar mania"],"prefix":"10.1016","volume":"29","author":[{"given":"Chi-Un","family":"Pae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Uk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Ho","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.04.024_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(02)00075-7","article-title":"Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study","volume":"76","author":"Altamura","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib4","article-title":"Quetiapine monotherapy for acute mania associated with bipolar disorder","author":"Brecher","year":"2003"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1034\/j.1399-5618.2002.02229.x","article-title":"Quetiapine in bipolar disorder and cocaine dependence","volume":"4","author":"Brown","year":"2002","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib6","article-title":"Double-blind, placebo-controlled study of quetiapine in bipolar depression","author":"Calabrese","year":"2004"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib8","doi-asserted-by":"crossref","unstructured":"Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, MD: National Institute of Mental Health, DHEW Pub. No. (ADM) 76\u2013338.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/CPP38053","article-title":"Predictability of the effects of race or ethnicity on pharmacokinetics of drugs","volume":"38","author":"Johnson","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib11","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder","author":"Jones","year":"2003"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/104454603321666216","article-title":"Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial","volume":"13","author":"McConville","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib13","article-title":"Quetiapine versus placebo as adjunct to lithium or divalproex for the treatment of bipolar mania","author":"Mullen","year":"2003"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hup.549","article-title":"Switching to quetiapine in patients with acute mania who were intolerant to risperidone","volume":"19","author":"Pae","year":"2004","journal-title":"Human Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib15","article-title":"Quetiapine monotherapy for the treatment of bipolar mania","author":"Paulsson","year":"2003"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4088\/JCP.v62n0911","article-title":"Quetiapine alone and added to a mood stabilizer for serious mood disorders","volume":"62","author":"Sajatovic","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.pnpbp.2005.04.024_bib18","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1399-5618.2002.01204.x","article-title":"Quetiapine in the treatment of rapid cycling bipolar disorder","volume":"4","author":"Vieta","year":"2002","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.024_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.04.024_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v61n0307","article-title":"Clinical predictors of acute response with quetiapine in psychotic mood disorders","volume":"61","author":"Zarate","year":"2000","journal-title":"J. Clin. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T22:49:28Z","timestamp":1586299768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0278584605001624"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.04.024","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}